Schwarzer Cardiotek Group develops, produces and distributes hemodynamic and electrophysiological measurement systems for the interventional cardiology field.
Schwarzer Cardiotek GmbH (Heilbronn, Germany) is a forward-thinking company at the forefront of developing innovative measurement systems for functional diagnostics of left/right-heart catheterization. Our integrated systems boast seamless integration with leading documentation and reporting platforms, while offering interoperability with all major X-ray manufacturers. With an impressive installation base exceeding 2000 systems globally, we have established ourselves as a trusted partner in the cardiology industry.
In the realm of electrophysiology, CardioTek B.V. (Sittard, The Netherlands) has been pioneering the development of the EP-TRACER®, a cutting-edge EP system renowned for its advanced technology since the 1980s. As the world’s first smallest portable EP lab with an integrated stimulator, our device sets the standard for signal quality and portability. In the 25 years since its foundation, CardioTek B.V. has successfully installed more than 1,500 EP systems in more than 70 countries worldwide.
Our unwavering commitment to maintaining the highest quality standards underscores our dedication to excellence.We are proud to have received both EN ISO 13485:2016 and MDSAP certification (for the USA, Brazil, Canada and Australia) as well as MDR approval for our hemodynamic measurement system. Moreover, our EP-TRACER® system received FDA 510(k) clearance for the first time in 2014 and its US market approval has been kept up-to-date ever since, affirming our commitment to meeting stringent regulatory requirements while delivering innovative solutions to our customers.
We strive towards the best possible quality
In our products, services and relationships
VISION
We aim to be a leading player in interventional cardiology by providing intelligent insights into cardiac function and by delivering best-in-class quality and service to our customers and partners to enhance the care of their patients.
MISSION
Schwarzer Cardiotek utilizes a comprehensive approach of creative thinking and expert collaboration to develop breakthrough innovations that improve clinician workflows.
We strive to develop long-term relationships with our customers and partners based on mutual trust and respect.
SMART. PRECISE. RELIABLE.
Frank-Peter Klein – President & CEO
Frank-Peter Klein was named Managing Director of Schwarzer Cardiotek in May of 2014. He has more than 30 years of experience in medical device technology and health informatics.
In the 1990s Frank-Peter Klein had already been General Manager, International Sales for Schwarzer. Under his leadership several milestones were achieved, including a worldwide OEM agreement for hemodynamic recording systems with Philips Healthcare. He later relocated to Paris where he led strategic marketing in cardiology for EMEA and Asia Pacific at GE Healthcare. Subsequently, he joined Defininens AG as a member of the Management Board and was entrusted with setting up and leading its medical division in cooperation with Nobel Prize laureate Professor Gerd Binning. Thereafter he served as Vice President, Sleep Disordered Breathing at ResMed and was appointed to the Board of Directors at BiancaMed Ltd., which was successfully sold to ResMed in 2011.